An independent RAS feasibility study tests whether an indoor recirculating facility can hold its design biomass, at its design energy cost, with enough mechanical redundancy to survive a failure — and whether the performance the pro forma assumes has been demonstrated at commercial scale or only claimed.
System-level technical review — biofiltration capacity, oxygenation, backup power as a life-support requirement — capex benchmarked per kilogram of annual capacity against the category's published build costs, commissioning and biological-ramp scheduling, and a power-interruption risk analysis with mitigation stated as conditions.
Every Wert-Berater financial model is fully linked with no hardcoded values, so any reviewer can stress any input. Deliverables comprise a complete narrative report and the linked Excel model, with ten-year pro forma, sensitivity analysis at ±5, 10, and 15 percent, interest-rate stress from +0.5 to +3.0 percent, and ratio analysis presented against the operating assumptions actually used in the model. Benchmarks are sourced and dated in the report — from published federal series, state agency reporting, extension budgets and named industry reporting — rather than asserted from a subscription database the reader cannot open.
RAS facilities are usually financed as rural business or industrial projects rather than as farms, though the enterprise's structure governs which programmes apply. USDA Rural Development guaranteed lending under 7 CFR Part 5001 may apply where the borrower and project meet the applicable eligibility and location criteria; Farm Service Agency farm loan programmes and Farm Credit System institutions serve operations organised as farming enterprises; SBA 7(a) and 504 structures serve owner-operator businesses meeting SBA size and eligibility criteria; and conventional and institutional lenders apply their own coverage standards.
Capital intensity is the defining credit characteristic. Because the ratio of capital cost to revenue is high, coverage is thin against construction overrun and ramp delay, and lenders in this category routinely require substantial equity, completion support and contingency. We prepare the study to the coverage test the specific lender applies, size contingency explicitly, and model the ramp rather than assuming design capacity from year one. Eligibility is determined by the lender and the agency on the applicant's facts, not by us.
Wert-Berater has no published recirculating aquaculture engagement, and we will not present an unrelated study as though it were one. What the firm brings to a RAS study is the capital-project discipline this category demands: construction cost tested against contingency, a modelled ramp to design capacity rather than an assumed one, a continuous industrial energy load priced from the actual tariff including demand charges, and a mechanical-failure stress case carried through to coverage.
Where a RAS engagement is completed and published, it will be named here with its location, programme and evaluated value. Until then this section describes method rather than a record.
A RAS feasibility study consultant analyses whether an indoor recirculating facility can produce its design output at its design cost and service debt while doing so. The analysis is organised around three quantities that determine everything else: the standing biomass the system can actually hold, the energy required to hold it, and the redundancy available when a component fails.
Wert-Berater tests the commercial and financial consequences of a system design. We use the specifications, capacity calculations and biological parameters supplied by the project's qualified engineers and biologists as inputs. We do not replace process engineering, water-quality engineering, commissioning or biological system design, and we do not certify that a design will perform as specified. Our contribution is to establish what the design implies for revenue, cost, coverage and risk — and to test whether the financial case survives the specification being missed.
Standing biomass is the revenue ceiling. It is set by the weakest link in the treatment train — typically biofilter capacity to process nitrogenous waste, oxygen delivery, solids removal, or degassing — and not by tank volume, which is the figure applicant projections most often cite. A facility with abundant tank volume and an undersized biofilter is limited by the biofilter, and every revenue line in the model must be built on that limit.
We take the engineer's capacity calculations as inputs and check that the production plan is internally consistent with them: that peak standing biomass across all cohorts at the busiest point of the rotation stays within stated capacity, and that the plan does not implicitly assume every tank is simultaneously at maximum. Where the production schedule exceeds the design envelope, the study models the output the design supports and reports the difference in revenue terms.
Recirculation reduces water use but does not eliminate it. Make-up water is required continuously to replace evaporation, solids removal and backwash, and its availability, quality and cost are site constraints with financial consequences. Discharge is the mirror problem: the concentrated waste stream a RAS produces must go somewhere permitted, and the permitted route — municipal sewer at volumetric and strength-based rates, on-site treatment with its own capital and operating cost, or land application — can differ in cost by a wide margin.
We model make-up water and discharge as line items priced from the actual utility tariffs and permit conditions at the site, not as a nominal allowance. Where the discharge permit limits loading, that limit caps biomass and therefore revenue, and the study establishes it before the pro forma is built rather than discovering it afterwards.
A RAS facility runs pumps, blowers, oxygen generation or delivery, heating or chilling, and treatment equipment continuously. Energy is normally among the largest operating costs and is highly sensitive to design, so it is modelled from the connected load and duty cycle of the specified equipment rather than from a per-pound estimate.
Crucially, energy is priced against the actual tariff schedule at the site, including demand charges. A facility with a large continuous draw can incur demand-based charges that materially change the cost per pound, and these are among the most frequently omitted items in applicant budgets. Thermal load is modelled to the species' temperature requirement against the local climate: heating a coldwater species in a warm region, or a warmwater species in a cold one, is a permanent cost the site imposes. Energy price is stressed as a sensitivity, because a facility can meet every biological target and still lose coverage to a tariff change.
In a recirculating system the fish depend entirely on machinery. An interruption in oxygen delivery or water movement is measured in minutes before losses begin, which makes redundancy and backup power survival infrastructure rather than optional capital.
We examine the redundancy actually specified — N+1 on critical components, automatic changeover, backup power sizing and fuel autonomy, alarm and response protocols, staffing coverage overnight and at weekends — and we model the financial consequence of the failure the design does not cover. That stress case removes standing biomass, applies the restart and regrow period, and carries the facility through the revenue gap while debt service, energy and labour continue. A RAS credit that depends on nothing ever failing is not a sound credit, and the study says so when that is what the analysis shows.
This section exists because it is the single most common reason RAS projections fail. Technology vendors and system designers publish performance figures — feed conversion, growth rate, survival, energy per pound, biofilter throughput, stocking density — that may be entirely accurate under the conditions in which they were obtained, and those conditions are frequently a pilot system, a research facility, a short trial, or an installation operating at a fraction of the proposed scale.
We distinguish, explicitly and in writing, between three classes of evidence: performance demonstrated at commercial scale in a comparable installation over a sustained period; performance demonstrated at pilot or research scale; and performance projected by a vendor or designer but not yet demonstrated. Every material assumption in the model is labelled with which class it belongs to and where it came from.
Where a projection depends on assumptions in the second or third class, the study models the outcome if commercial performance falls short — longer grow-out, higher feed conversion, lower survival, higher energy per pound, lower achieved density — and reports coverage under that case alongside the base case. Scale-up is treated as a risk in its own right: performance at pilot scale does not reliably transfer to a commercial facility, and a lender is entitled to see what happens if it does not. We do not adopt a vendor figure merely because it is in the vendor's literature.
RAS projects are construction projects, and they carry construction risk that pond operations do not. Capital budgets are tested for completeness — building shell, tanks, treatment train, oxygen systems, controls, backup power, site work, permitting, professional fees, commissioning and pre-revenue operating cost — because omissions in this category tend to be systematic rather than random, and the omitted items are usually the unglamorous ones.
Contingency is sized explicitly rather than assumed. Just as importantly, the study models a ramp: a new facility does not reach design capacity on the day it opens. Systems must be biologically matured, staff trained, and cohorts built up through successive stockings, and the interval between commissioning and steady-state production is a period of full fixed cost against partial revenue. Modelling year one at design capacity is the second most common failure in this category, and we model the ramp the facility will actually experience, with debt service tested through it.
The model is fully linked with no hardcoded values, so a reviewer can change biomass capacity, energy price, feed conversion, survival, ramp length or achieved price and watch coverage respond. Revenue is built from the production the design supports on a cohort rotation; operating cost is built from the equipment schedule, the utility tariff, and the staffing a facility requiring continuous monitoring genuinely needs; and coverage is tested against the specific standard the lender applies.
Because capital intensity leaves little margin, sensitivity is run hard: energy price, feed cost, achieved density, survival, ramp duration, construction overrun and market price, individually and in combination. The study reports break-even production and price, the coverage outcome under a failure event, and the conditions under which the project does not work. The comparative economics against other systems are set out in our aquaculture feasibility study overview, and where the facility includes processing, that business is analysed on the seafood processing page.
This is an independent financial feasibility analysis. Wert-Berater does not replace process engineering, water-quality engineering, mechanical or electrical design, commissioning, or biological system design, and does not certify that a system will perform to specification. We are not fish-health or veterinary advisers and we do not provide permitting or legal advice. Qualified engineering and biological specifications are inputs to our analysis; our work is to test their commercial and financial consequences and to report what happens if they are not achieved. Wert-Berater does not hold or represent aquaculture-engineering, fisheries-science or marine-biology credentials.
A RAS feasibility study consultant analyses whether an indoor recirculating facility can produce its design output at its design cost and cover debt service. The analysis centres on the standing biomass the treatment train supports, the continuous energy required to hold it, the redundancy available when equipment fails, and the ramp from commissioning to steady-state production.
Wert-Berater tests commercial and financial consequences using the engineering and biological specifications supplied by qualified specialists as inputs. We do not replace process engineering, water-quality engineering, commissioning or biological design, and we do not certify that a system will perform as specified.
Biomass capacity is determined by the weakest link in the treatment train — commonly biofilter throughput, oxygen delivery, solids removal or degassing — and not by tank volume, which is the figure most often quoted in applicant projections.
We take the engineer's capacity calculations as inputs and test the production plan against them, including peak standing biomass across all cohorts at the busiest point of the rotation. Where the plan exceeds the design envelope, we model the output the design actually supports and report the revenue difference.
Energy is modelled from the connected load and duty cycle of the specified equipment — pumps, blowers, oxygen systems, heating or chilling, controls — and priced against the actual utility tariff at the site, including demand charges.
Demand charges are frequently omitted from applicant budgets and can materially change cost per pound for a facility with a large continuous draw. Thermal load is modelled to the species' temperature requirement against the local climate, and energy price is carried as a sensitivity because a tariff change alone can eliminate coverage.
Redundancy is evaluated as survival infrastructure rather than optional capital, because in a recirculating system an interruption to oxygen or water movement is measured in minutes before losses begin. We examine redundancy on critical components, automatic changeover, backup power sizing and fuel autonomy, alarm and response protocols, and overnight and weekend staffing coverage.
We then model the financial consequence of a failure the design does not cover: loss of standing biomass, the restart and regrow period, and the revenue gap while debt service, energy and labour continue. A credit that depends on nothing ever failing is not a sound credit.
Vendor and designer performance figures are classified rather than adopted. We distinguish performance demonstrated at commercial scale in a comparable installation over a sustained period, performance demonstrated at pilot or research scale, and performance projected but not demonstrated — and every material model assumption is labelled with its class and source.
Where a projection depends on undemonstrated performance, we model the shortfall case: longer grow-out, higher feed conversion, lower survival, higher energy per pound or lower achieved density, with coverage reported under that case alongside the base case. Scale-up is treated as a risk in its own right, because pilot performance does not reliably transfer to commercial scale.
Make-up water is analysed as a continuous requirement replacing evaporation, solids removal and backwash, priced from the actual water supply and tariff at the site. Recirculation reduces water use but does not remove the dependency.
Discharge is analysed as both a cost and a capacity constraint. The permitted route — municipal sewer at volumetric and strength-based rates, on-site treatment, or land application — varies widely in cost, and where a permit limits loading it also caps biomass and therefore revenue. That limit is established before the pro forma is built.
The ramp is modelled explicitly, because a new facility does not reach design capacity when it opens. Biological systems must mature, staff must be trained, and cohorts must be built up through successive stockings, so there is an interval of full fixed cost against partial revenue.
We model that interval on a realistic schedule and test debt service through it, including the sizing of interest reserve or deferred amortisation where applicable. Modelling year one at design capacity is one of the most common and most damaging errors in RAS projections.
Capital budgets are tested for completeness across building shell, tanks, treatment train, oxygen systems, controls, backup power, site work, permitting, professional fees, commissioning and pre-revenue operating cost. Omissions in this category tend to be systematic, and the missing items are usually the unglamorous ones.
Contingency is sized explicitly rather than assumed, and overrun is carried as a sensitivity. Because capital intensity leaves coverage thin, a moderate overrun combined with a ramp delay is often the case that decides whether the credit is sound, and the study reports it directly.
No. Wert-Berater does not perform process engineering, water-quality engineering, mechanical or electrical design, commissioning or biological system design, and does not certify that a system will perform to specification. We do not hold or represent aquaculture-engineering, fisheries-science or marine-biology credentials.
We use the specifications and capacity calculations produced by the project's qualified engineers and biologists as inputs, and test what they mean financially — including what happens to coverage if the specified performance is not achieved. That separation is deliberate and is stated in every report.
Fee depends on facility scale, the number of species and production modules, whether processing or hatchery operations are included, the complexity of the utility and discharge arrangements, and the programme the study must satisfy.
We quote a fixed fee after a short scoping conversation covering the system design, the site, the market and the lender or agency involved, so the figure reflects the actual analysis rather than a published range. Timeline is agreed at the same point and usually depends on how quickly engineering documentation becomes available.
Qualify a project. Tell us about the project and the program. We will tell you the truth about it — scope, timeline, and fee confirmed before work begins.
Schedule a Zoom Call →Legal disclosure. Wert-Berater, Inc. offices are mailing addresses only. Following the COVID-19 pandemic the firm has elected to work remotely; its office locations receive mail and are not staffed for visitors or in-person meetings. Headquarters mailing address: 1968 South Coast Hwy, Ste 2382, Laguna Beach, CA 92651.
Wert-Berater, Inc. is an independent provider of feasibility studies and other related services. The firm does not provide financing or equity investment advice, and does not arrange, broker, or place debt or equity capital of any kind.
All appraisal assignments are performed by Bruce E. Jones, MAI, ASA-GC, BCA, CMEA, a member of the Appraisal Institute since 2006, a staff member of Wert-Berater, Inc. and owner of Special Purpose Realty Valuation.